Despite months of furious debate over Brexit, few have talked about its potential implications for the pharmaceutical industry and medical research. When the UK leaves the EU, the prospects for British pharmaceuticals may be dim. This is increasingly apparent as a hard Brexit seems ever more likely, with no deal between the UK and the EU at the … [Read more...] about Brexit uncertainty, blocking both medicines and migrants?
The UK government has put forward ambitious plans for the pharmaceutical industry since Brexit. Though seemingly enterprising, there are worries that these plans simply appear promising on paper and do not have enough resources to see them through. Brexit has been marred by uncertainty since the UK voted to leave the European Union. The prospect … [Read more...] about Ambitious goals for UK Pharma, does the budget match up?
This is one of those dense academic papers that might seem to use arcane processes to get at the blindingly obvious. However, there are gems of great information within it so we advise you to stick with it. Published in the May 2013 Globalization and Health, it's got the uncatchy title of Understanding how and why health is integrated into foreign … [Read more...] about Why do UK governments invest in global public health? Academic paper contains nuggets